Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Inflammation × Genitourinary × Clear all

Phase

Phase 2 2 Phase NA 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 420 Urinary Bladder Neoplasms 119 Carcinoma, Renal Cell 103 Neoplasms 55 Kidney Neoplasms 43 Non-Muscle Invasive Bladder Neoplasms 39 Carcinoma, Transitional Cell 33 Neoplasm Metastasis 32 Breast Neoplasms 24 Testicular Neoplasms 23 Recurrence 16 Parkinson Disease 4, Autosomal Dominant Lewy Body 14 Wilms Tumor 11 Testicular Germ Cell Tumor 10 Seminoma 10 Ovarian Neoplasms 10 Multiple Myeloma 10 Carcinoma 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Pain 9 Osteoporosis 9 Lung Neoplasms 9 Burkitt Lymphoma 9 Urologic Neoplasms 8 Urethral Neoplasms 8 Teratoma 8 Lymphoma, Non-Hodgkin 8 Lymphoma, Mantle-Cell 8 Lymphoma, Large-Cell, Immunoblastic 8 Lymphoma, Large B-Cell, Diffuse 8

Interventions

Tea 1 Sufentanil 1 Morphine 1 Analgesia, Patient-Controlled 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01367418 2012-03-19

AIMS

Örebro University, Sweden

Phase 3 Completed

Inflammation, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡